Literature DB >> 33978321

Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model.

Kayla R Nygaard1,2, Raylynn G Swift1,2, Rebecca M Glick1,2, Rachael E Wagner2, Susan E Maloney2,3, Georgianna G Gould4, Joseph D Dougherty1,2,3.   

Abstract

Williams Syndrome results in distinct behavioral phenotypes, which include learning deficits, anxiety, increased phobias and hypersociability. While the underlying mechanisms driving this subset of phenotypes is unknown, oxytocin (OT) dysregulation is hypothesized to be involved as some studies have shown elevated blood OT and altered OT receptor expression in patients. A "Complete Deletion" (CD) mouse, modeling the hemizygous deletion in Williams Syndrome, recapitulates many of the phenotypes present in humans. These CD mice also exhibit impaired fear responses in the conditioned fear task. Here, we address whether OT dysregulation is responsible for this impaired associative fear memory response. We show direct delivery of an OT receptor antagonist to the central nervous system did not rescue the attenuated contextual or cued fear memory responses in CD mice. Thus, increased OT signaling is not acutely responsible for this phenotype. We also evaluated OT receptor and serotonin transporter availability in regions related to fear learning, memory and sociability using autoradiography in wild type and CD mice. While no differences withstood correction, we identified regions that may warrant further investigation. There was a nonsignificant decrease in OT receptor expression in the lateral septal nucleus and nonsignificant lowered serotonin transporter availability in the striatum and orbitofrontal cortex. Together, these data suggest the fear conditioning anomalies in the Williams Syndrome mouse model are independent of any alterations in the oxytocinergic system caused by deletion of the Williams locus.
© 2021 International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.

Entities:  

Keywords:  OXTR; SERT; Williams Syndrome; associative fear; autoradiography; behavioral genetics; conditioned fear; mouse model; oxytocin; oxytocin receptor antagonist

Mesh:

Substances:

Year:  2021        PMID: 33978321      PMCID: PMC8842878          DOI: 10.1111/gbb.12750

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  73 in total

1.  Honing in on the social phenotype in Williams syndrome using multiple measures and multiple raters.

Authors:  Bonita P Klein-Tasman; Kirsten T Li-Barber; Erin T Magargee
Journal:  J Autism Dev Disord       Date:  2011-03

Review 2.  The behavioral phenotype of Williams syndrome: A recognizable pattern of neurodevelopment.

Authors:  Colleen A Morris
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-11-15       Impact factor: 3.908

3.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

Review 4.  I. The neurocognitive profile of Williams Syndrome: a complex pattern of strengths and weaknesses.

Authors:  U Bellugi; L Lichtenberger; W Jones; Z Lai; M St George
Journal:  J Cogn Neurosci       Date:  2000       Impact factor: 3.225

5.  Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner.

Authors:  Iulia Toth; Inga D Neumann; David A Slattery
Journal:  Psychopharmacology (Berl)       Date:  2012-04-20       Impact factor: 4.530

6.  Prolonged fear responses in mice lacking dopamine D1 receptor.

Authors:  M El-Ghundi; B F O'Dowd; S R George
Journal:  Brain Res       Date:  2001-02-16       Impact factor: 3.252

7.  Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory.

Authors:  Z Khuchua; D F Wozniak; M E Bardgett; Z Yue; M McDonald; J Boero; R E Hartman; H Sims; A W Strauss
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Dysregulation of the oxytocin receptor gene in Williams syndrome.

Authors:  Ryo Kimura; Kiyotaka Tomiwa; Ryo Inoue; Shiho Suzuki; Masatoshi Nakata; Tomonari Awaya; Takeo Kato; Shin Okazaki; Toshio Heike; Masatoshi Hagiwara
Journal:  Psychoneuroendocrinology       Date:  2020-02-20       Impact factor: 4.905

9.  Oxytocin, vasopressin, and Williams syndrome: epigenetic effects on abnormal social behavior.

Authors:  Brian W Haas; Alicia K Smith
Journal:  Front Genet       Date:  2015-02-17       Impact factor: 4.599

10.  Oxytocin enhances observational fear in mice.

Authors:  Marc T Pisansky; Leah R Hanson; Irving I Gottesman; Jonathan C Gewirtz
Journal:  Nat Commun       Date:  2017-12-13       Impact factor: 14.919

View more
  1 in total

Review 1.  Oxytocin and Oxytocin Receptor Gene Regulation in Williams Syndrome: A Systematic Review.

Authors:  Elif Çalışkan; Munise Nur Şahin; Mahmut Alper Güldağ
Journal:  Yale J Biol Med       Date:  2021-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.